Acetylcholinesterase inhibition promotes retinal vasoprotection and increases ocular blood flow in experimental glaucoma

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 5, 2013, Pages 3171-3183

  Almasieh, Mohammadali ^a   MacIntyre, Jessica N ^b   Pouliot, Mylène ^a   Casanova, Christian ^a   Vaucher, Elvire ^a   Kelly, Melanie E M ^b   Di Polo, Adriana ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Acetylcholinesterase inhibitors; Blood flow; Glaucoma; Muscarinic receptors; Retinal ganglion cells; Retinal vessels

Indexed keywords

GALANTAMINE; MUSCARINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD VESSEL REACTIVITY; CELL DEATH; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; GLAUCOMA; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; RETINA CAPILLARY; RETINA GANGLION CELL;

ACETYLCHOLINESTERASE INHIBITORS; BLOOD FLOW; GLAUCOMA; MUSCARINIC RECEPTORS; RETINAL GANGLION CELLS; RETINAL VESSELS;

ACETYLCHOLINESTERASE; ANIMALS; AUTORADIOGRAPHY; CELL COUNT; CELL SURVIVAL; CHOLINESTERASE INHIBITORS; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GALANTAMINE; INJECTIONS, INTRAPERITONEAL; INTRAOCULAR PRESSURE; MALE; OCULAR HYPERTENSION; RATS; RATS, INBRED BN; RECEPTORS, MUSCARINIC; REGIONAL BLOOD FLOW; RETINAL GANGLION CELLS; RETINAL VESSELS; VASODILATION;

EID: 84877153225     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11481     Document Type: Article

References (72)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:1965-1972.
3. Cherecheanu AP, Garhofer G, Schmidl D, Werkmeister R, Schmetterer L. Ocular perfusion pressure and ocular blood flow in glaucoma. Curr Opin Pharmacol. 2012;13:1-7.
4. Drance S. Disc hemorrhages in the glaucomas. Surv Ophthalmol. 1989;33:331-337.
5. Grieshaber MC, Mozaffarieh M, Flammer J. What is the link between vascular dysregulation and glaucoma? Surv Ophthalmol. 2007;52:S144-S154.
6. Kornzweig A, Eliasoph I, Feldstein M. Selective atrophy of the radial peripapillary capillaries in chronic glaucoma. Arch Ophthalmol. 1968;80:696-702.
7. Osborne NN, Melena J, Chidlow G, Wood JP. A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma. Br J Ophthalmol. 2001;85:1252-1259.
8. Michelson G, Langhans M, Groh M. Perfusion of the juxtapapillary retina and the neuroretinal rim area in primary open angle glaucoma. J Glaucoma. 1996;5:91-98.
9. Yamazaki Y, Drance S. The relationship between progression of visual field defects and retrobulbar circulation in patients with glaucoma. Am J Ophthalmol. 1997;124:287-295.
10. Grunwald JE, Piltz J, Hariprasad SM, DuPont J. Optic nerve and choroidal circulation in glaucoma. Invest Ophthalmol Vis Sci. 1998;39:2329-2336.
11. Findl O, Rainer G, Dallinger S, et al. Assessment of optic disk blood flow in patients with open-angle glaucoma. Am J Ophthalmol. 2000;130:589-596.
12. Portmann N, Gugleta K, Kochkorov A, Polunina A, Flammer J, Orgul S. Choroidal blood flow response to isometric exercise in glaucoma patients and patients with ocular hypertension. Invest Ophthalmol Vis Sci. 2011;52:7068-7073.
13. Wang Y, Fawzi A, Varma R, et al. Pilot study of optical coherence tomography measurement of retinal blood flow in retinal and optic nerve diseases. Invest Ophthalmol Vis Sci. 2011;52:840-845.
14. Mitchell P, Leung H, Wang JJ, et al. Retinal vessel diameter and open-angle glaucoma: the Blue Mountains Eye Study. Ophthalmology. 2005;112:245-250.
15. Amerasinghe N, Aung T, Cheung N, et al. Evidence of retinal vascular narrowing in glaucomatous eyes in an Asian population. Invest Ophthalmol Vis Sci. 2008;49:5397-5402.
16. Gottanka J, Kuhlmann A, Scholz M, Johnson DH, Lutjen- Drecoll E. Pathophysiologic changes in the optic nerves of eyes with primary open angle and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci. 2005;46:4170-4181.
17. Grunwald J, Riva C, Stone R, Keates E, Petrig B. Retinal autoregulation in open-angle glaucoma. Ophthalmology. 1984;91:1690-1694.
18. Schmidl D, Garhofer G, Schmetterer L. The complex interaction between ocular perfusion pressure and ocular blood flow-relevance for glaucoma. Exp Eye Res. 2011;93: 141-155.
19. Garhöfer G, Zawinka C, Resch H, Huemer K, Schmetterer L, Dorner G. Response of retinal vessel diameters to flicker stimulation in patients with early open angle glaucoma. J Glaucoma. 2004;13:340-344.
20. Gugleta K, Kochkorov A, Waldmann N, et al. Dynamics of retinal vessel response to flicker light in glaucoma patients and ocular hypertensives. Graefes Arch Clin Exp Ophthalmol. 2012;250:589-594.
21. Kaiser H, Flammer J, Wenk M, Lüscher T. Endothelin-1 plasma levels in normal-tension glaucoma: abnormal response to postural changes. Graefes Arch Clin Exp Ophthalmol. 1995; 233:484-488.
22. Tezel G, Kass M, Kolker A, Becker B, Wax M. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma. 1997;6:83-89.
23. Emre M, Orgül S, Haufschild T, Shaw SG, Flammer J. Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma. Br J Ophthalmol. 2005;89:60-63.
24. Choritz L, Machert M, Thieme H. Correlation of endothelin-1 concentration in aqueous humor with intraocular pressure in primary open angle and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci. 2012;53:7336-7342.
25. Resch H, Karl K, Weigert G, et al. Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects. Invest Ophthalmol Vis Sci. 2009;50:358-363.
26. Sapieha P. Eyeing central neurons in vascular growth and reparative angiogenesis. Blood. 2012;120:2182-2194.
27. Morrison JC, Moore CG, Deppmeier LMH, Gold BG, Meshul CK, Johnson EC. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res. 1997;64:85-96.
28. Mickala P, Boutin H, Bellanger C, Chevalier C, MacKenzie ET, Dauphin F. In vivo binding, pharmacokinetics and metabolism of the selective M2 muscarinic antagonist. Nucl Med Biol. 1996;23:173-179.
29. Stein R, Bachoo M, Polosa C. Pirenzepine-sensitive component of forelimb vascular resistance and heart rate in cats. J Autonom Nerv Syst. 1995;54:49-58.
30. Almasieh M, Zhou Y, Kelly MEM, Casanova C, Di Polo A. Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors. Cell Death Dis. 2010;1:e7.
31. Lebrun-Julien F, Duplan L, Pernet V, et al. Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism. J Neurosci. 2009;29:5536-5545.
32. Pouliot M, Deschênes MC, Hétu S, et al. Quantitative and regional measurement of retinal blood flow in rats using Nisopropyl- p-[14C]-iodoamphetamine ([14C]-IMP). Exp Eye Res. 2009;89:960-966.
33. Ninomiya H, Kuno H. Microvasculature of the rat eye: scanning electron microscopy of vascular corrosion casts. Vet Ophthalmol. 2001;4:55-59.
34. Puro DG. Retinovascular physiology and pathophysiology: new experimental approach/new insights. Prog Ret Eye Res. 2012;31:258-270.
35. Vidal-Sanz M, Villegas-Perez MP, Bray GM, Aguayo AJ. Persistent retrograde labeling of adult rat retinal ganglion cells with the carbocyanine dye diI. Exp Neurol. 1988;102:92-101.
36. Ago Y, Koda K, Takuma K, Matsuda T. Pharmacological aspects of the acetylcholinesterase inhibitor galantamine. J Pharmacol Sci. 2011;116:6-17.
37. Schrattenholz A, Pereira EF, Roth U, Weber KH, Albuquerque EX, Maelicke A. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol Pharmacol. 1996;49:1-6.
38. Howell GR, Libby RT, Jakobs TC, et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol. 2007;179:1523-1537.
39. Nickells RW, Howell GR, Soto I, John SWM. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Ann Rev Neurosci. 2012;35:153-179.
40. Whitmore AV, Libby RT, John SW. Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and other compartmentalised processes? Prog Retin Eye Res. 2005;24:639-662.
41. Morquette JB, Di Polo A. Dendritic and synaptic protection: is it enough to save the retinal ganglion cell body and axon? J Neuroophthalmol. 2008;28:144-154.
42. Rosen AM, Stevens B. The role of the classical complement cascade in synapse loss during development and glaucoma. Adv Exp Med Biol. 2010;703:75-93.
43. Howell GR, Macalinao DG, Sousa GL, et al. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest. 2011;121:1429-1444.
44. Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog Ret Eye Res. 2012;31:152-181.
45. Lafuente MP, Villegas-Pérez MP, Sellés-Navarro I, Mayor- Torroglosa S, Miralles de Imperial J, Vidal-Sanz M. Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult. Neuroscience. 2002;109:157-168.
46. Sellés-Navarro I, Villegas-Pérez MP, Salvador-Silva M, Ruiz-Gómez JM, Vidal-Sanz M. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest Ophthalmol Vis Sci. 1996;37:2002-2014.
47. Butryn RK, Ruan H, Hull CM, Frank RN. Vasoactive agonists do not change the caliber of retinal capillaries of the rat. Microvasc Res. 1995;50:80-93.
48. Lecrux C, Hamel E. The neurovascular unit in brain function and disease. Acta Physiol. 2011;203:47-59.
49. Srienc AI, Kurth-Nelson ZL, Newman E. Imaging retinal blood flow with laser speckle flowmetry. Front Neuroenerg. 2010;2: 1-10.
50. Rigosi E, Ensini M, Bottari D, Leone P, Galli-Resta L. Loss of retinal capillary vasoconstrictor response to endothelin-1 following pressure increments in living isolated rat retinas. Exp Eye Res. 2010;90:33-40.
51. Sapieha P, Sirinyan M, Hamel D, et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med. 2008;14:1067-1076.
52. Edwards MM, McLeod DS, Li R, et al. The deletion of Math5 disrupts retinal blood vessel and glial development in mice. Exp Eye Res. 2012;96:147-156.
53. Kur J, Newman EA, Chan-Ling T. Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease. Prog Ret Eye Res. 2012;31: 377-406.
54. Pournaras CJ, Rungger-Brändle E, Riva CE, Hardarson SH, Stefansson E. Regulation of retinal blood flow in health and disease. Prog Ret Eye Res. 2008;27:284-330.
55. Vidal-Sanz M, Salinas-Navarro M, Nadal-Nicolás FM, et al. Understanding glaucomatous damage: anatomical and functional data from ocular hypertensive rodent retinas. Prog Ret Eye Res. 2012;31: 1-27.
56. Salinas-Navarro M, Alarcón-Martínez L, Valiente-Soriano F, et al. Functional and morphological effects of laser-induced ocular hypertension in retinas of adult albino Swiss mice. Mol Vis. 2009;15:2578-2598.
57. Moon J-I, Kim I-B, Gwon J-S, et al. Changes in retinal neuronal populations in the DBA/2J mouse. Cell Tissue Res. 2005;320: 51-59.
58. Gunn DJ, Gole GA, Barnett NL. Specific amacrine cell changes in an induced mouse model of glaucoma. Clin Exp Ophthalmol. 2011;39:555-563.
59. Jakobs TC, Libby RT, Ben Y, John SW, Masland RH. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol. 2005;171:313-325.
60. Kielczewski JL, Pease ME, Quigley HA. The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest Ophthalmol Vis Sci. 2005;46:3188-3196.
61. Vickers JC, Schumer RA, Podos SM, Wang RF, Riederer BM, Morrison JH. Differential vulnerability of neurochemically identified subpopulations of retinal neurons in a monkey model of glaucoma. Brain Res. 1995;680:23-35.
62. Gur M, Zeevi YY, Bielik M, Neumann E. Changes in the oscillatory potentials of the electroretinogram in glaucoma. Curr Eye Res. 1987;6:457-466.
63. Nakao A, Kaczorowski D, Zuckerbraun B, et al. Galantamine and carbon monoxide protect brain microvascular endothelial cells by heme oxygenase-1 induction. Biochem Biophys Res Commun. 2008;367:674-679.
64. Lee N-Y, Choi H-O, Kang Y-S. The acetylcholinesterase inhibitors competitively inhibited an acetyl L-carnitine transport through the blood-brain barrier. Neurochem Res. 2012; 37:1499-1507.
65. Sung J-H, Yu K-H, Park J-S, et al. Saturable distribution of tacrine into the striatal extracellular fluid of the rat: evidence of involvement of multiple organic cation transporters in the transport. Drug Metab Dispos. 2005;33:440-448.
66. Sastry BV. Cholinergic systems and multiple cholinergic receptors in ocular tissues. J Ocul Pharmacol Ther. 1985;1: 201-226.
67. Elhusseiny A, Cohen Z, Olivier A, Stanimirović DB, Hamel E. Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: identification and cellular localization. J Cereb Blood Flow Metab. 1999;19:794-802.
68. Dauphin F, Linville DG, Hamel E. Cholinergic dilatation and constriction of feline cerebral blood vessels are mediated by stimulation of phosphoinositide metabolism via two different muscarinic receptor subtypes. J Neurochem. 1994;63:544-551.
69. Bény J-L, Nguyen M, Marino M, Matsui M. Muscarinic receptor knockout mice confirm involvement of M3 receptor in endothelium-dependent vasodilatation in mouse arteries. J Cardiovasc Pharmacol. 2008;51:505-512.
70. Lipton SA, Aizenman E, Loring RH. Neural nicotinic acetylcholine responses in solitary mammalian retinal ganglion cells. Pflügers Arch. 1987;410:37-43.
71. Da Silva N, Herron C, Stevens K, Jollimore CAB, Barnes S, Kelly MEM. Metabotropic receptor-activated calcium increases and store-operated calcium influx in mouse Müller cells. Invest Ophthalmol Vis Sci. 2008;49:3065-3073.
72. Borda E, Berra A, Saravia M, Ganzinelli S, Sterin Borda L. Correlations between neuronal nitric oxide synthase and muscarinic M3/M1 receptors in the rat retina. Exp Eye Res. 2005;80:391-399.